SATIS_1170x120_1-25-21

added Zembrace SymTouch (sumatriptan) Injection 3 mg to its Access Pathways Platinum Pass Program

Upsher-Smith adds Zembrace SymTouch (sumatriptan) Injection to program

Upsher-Smith adds Zembrace SymTouch (sumatriptan) Injection to program

MAPLE GROVE, Minn. — Upsher-Smith announced Monday that it has added Zembrace SymTouch (sumatriptan) Injection 3 mg to its Access Pathways Platinum Pass Program – a savings and support program where eligible patients pay $0 per prescription. Zembrace SymTouch is indicated for the acute treatment of migraine with or without aura in adults. It provides migraine pain